NeuroStar Celebrates Milestone in Suicide Prevention Efforts
MALVERN, Pa. – Neuronetics, Inc. (NASDAQ: STIM) is a committed medical technology company focused on improving the lives of patients dealing with neurohealth disorders. In recognition of Suicide Prevention Month, the company is excited to showcase the impactful stories shared through the NeuroStar Voices Portal. Launched last year, this platform provides a vital space for individuals to share their experiences with depression and the transformative effects of NeuroStar Advanced Therapy.
Achieving a Significant Milestone
Neuronetics is excited to announce that it has reached a noteworthy milestone, having achieved half of its ambitious goal to save 3,325 lives through this innovative therapy. Since NeuroStar's launch, over 88,533 patients have been treated, leading to an estimated 1,771 lives saved. This achievement is part of a larger five-year initiative aimed at treating 166,240 individuals with NeuroStar TMS, reflecting remarkable progress since the therapy received FDA clearance in 2008. The increase in patients treated in recent years signifies a significant advancement in the ongoing battle against depression.
The Impact of NeuroStar Advanced Therapy
“Setting the goal of saving 3,325 lives was more than just a target—it was a heartfelt promise to offer hope to those facing mental health challenges,” said Keith J. Sullivan, President and CEO of Neuronetics, Inc. “Reaching this halfway mark serves as a reminder that each life saved represents the bravery of those fighting depression and the profound impact NeuroStar has on their recovery journey. The touching stories shared through the NeuroStar Voices Portal help to personalize these milestones, highlighting the life-changing benefits of our therapy and the renewed hope it brings to countless individuals and their families.”
Inspiring Testimonials from Patients
The NeuroStar Voices Portal features compelling testimonials from patients who have experienced life-saving changes due to NeuroStar TMS therapy. Here are a few of their inspiring stories:
- "My life has completely changed since NeuroStar TMS. I tell everybody all the time that it did not just change my life, but it saved my life." – Kayla
- "NeuroStar TMS was probably the best thing that could have happened. I feel so much freer without that heaviness of depression. There's light now." – Curry
- "I want people with depression to know that THEY are worth the time commitment, the effort, and the healing NeuroStar TMS will bring to help them return to a productive, happy life!" – Kat
The Need for Ongoing Mental Health Innovation
Recent data from the Centers for Disease Control and Prevention reveals a troubling trend, with nearly 50,000 suicide deaths reported in a single year, highlighting a critical need for effective mental health treatments. This underscores the urgency for ongoing innovation and dedicated efforts in mental health care, illustrating how NeuroStar plays a vital role in providing support and hope to those in distress.
About Neuronetics and NeuroStar Advanced Therapy
Neuronetics, Inc. is dedicated to recognizing the essential nature of mental health alongside physical health. As a global leader in neuroscience, the company is changing expectations for both patients and healthcare providers through its NeuroStar Advanced Therapy for Mental Health. This non-drug, non-invasive treatment significantly enhances the quality of life for those suffering from neurohealth disorders when traditional medications are ineffective. Specifically, NeuroStar is designed for treating depressive episodes and alleviating anxiety symptoms in individuals affected by Major Depressive Disorder (MDD).
For more information regarding the remarkable impact of NeuroStar TMS Therapy or for safety and prescribing details, visit www.neurostar.com.
Frequently Asked Questions
What is NeuroStar Advanced Therapy?
NeuroStar Advanced Therapy is a non-invasive treatment for depression that has proven effective for patients when traditional medications have not worked.
How many patients has NeuroStar treated?
Currently, NeuroStar has treated over 88,533 patients, showcasing its significant impact in the realm of mental health.
What are the goals of the neurohealth initiative?
Neuronetics aims to treat 166,240 individuals and save 3,325 lives through its innovative NeuroStar TMS treatment over the next five years.
How can I learn more about NeuroStar's achievements?
The NeuroStar Voices Portal is an excellent resource for detailed stories and information, showcasing a variety of experiences from individuals affected by the therapy.
What should I do if I or someone I know is struggling with depression?
It's crucial to seek help. Consider discussing treatment options with a healthcare provider and exploring services like NeuroStar Advanced Therapy.
